Skip to main content
Institutional deep-dive - valuation, health, statements

Financial Analysis

Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data

Fundamentals

Verrica Pharmaceuticals Inc. VRCA

· Materials · Pharmaceutical Preparations

FY2025 10-K, filed 2026-03-11
SEC EDGAR

Filing evidence summary

Mixed evidenceCoverage 5/5 core metrics

Latest reported free cash flow was -$18M.

Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.

Evidence signals

  • Free cash flow was negative

    Latest reported free cash flow was -$18M.

    Why this surfaced

    Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.

  • 3 filing risk checks flagged

    Flagged areas: Earnings quality, Solvency & liquidity.

    Why this surfaced

    The full financial analysis shows each value, threshold, and sector limitation.

  • Revenue expanded

    Latest reported annual revenue changed +370.2% from the prior reported annual observation.

    Why this surfaced

    Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-12-31.

  • Operating margin improved

    Operating margin changed +837.0 percentage points from the prior annual period.

    Why this surfaced

    Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-12-31.

Core trend metrics

Latest annual revenue growth
+370.2%
as of 2025-12-31
Latest annual operating margin
-34.2%
as of 2025-12-31
Free cash flow
-$18M
as of 2025-12-31
Debt / equity
0.00x
as of 2025-12-31
ROIC snapshot
-37.1%
period varies

Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.

Where to look next

Risk checks

3of 10 rule-based checks flagged
  • Earnings quality
  • Solvency & liquidity

Financial movement

  • Cash→ flat
  • Long-term debt→ flat
  • Inventory→ flat
  • Receivables→ flat
  • Current assets→ flat

Source & freshness

Source
SEC EDGAR XBRL
Fetched
2026-09-06
Latest period end
2025-12-31
Filings
EDGAR ↗

Reported segment mix

figures as filed · share of the filed sum · change vs the prior period in the same filing
Fiscal year ending 2025-12-3110-K filed 2026-03-11prior period 2024-12-31 from the same filingView filing
By business segment
Revenue
  • Operating Segment$35.6M
    100.0%
    +370.2% yoy

Members sum to the consolidated $35.6M for this period.

By product or service
Revenue
  • License And Collaboration Revenue$20.3M
    57.0%
    +1945.6% yoy
  • Product$15.3M
    43.0%
    +132.5% yoy

Members sum to the consolidated $35.6M for this period.

Latest quarter
Quarter ending 2026-03-3110-Q filed 2026-05-12prior period 2025-03-31 from the same filingView filing
  • Reportable Segment$5.02M
    100.0%
    +46.1% yoy

Change is against the same quarter a year earlier, as reported in the same 10-Q.

Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.

Peer percentiles

latest fiscal year ending 2025-12-31 · among 4,007 US-listed filers · 781 in Materials
MetricValuevs all filersvs sector
Revenue
latest fiscal-year revenue as filed
$36M
19thof 3,301
bottom third
32ndof 522
bottom third
Revenue growth
latest fiscal-year revenue vs the prior fiscal year
370.2%
98thof 3,137
top third
93rdof 473
top third
Operating margin
operating income ÷ revenue
-34.3%
23rdof 2,819
bottom third
48thof 483
middle third
Net margin
net income ÷ revenue
-50.3%
19thof 3,263
bottom third
41stof 518
middle third
Free-cash-flow margin
(operating cash flow − |capex|) ÷ revenue
-49.5%
15thof 2,679
bottom third
38thof 433
middle third
Return on equity
net income ÷ stockholders' equity (positive equity only)
-72.3%
15thof 3,576
bottom third
31stof 701
bottom third
Days sales outstanding
receivables ÷ revenue × 365 · lower is ranked higher
54 days
44thof 2,398
middle third
48thof 387
middle third

Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.

Earnings quality

Not available for VRCA yet: Earnings-quality fields arrive with this issuer's next re-crawl (sec_screen_v6)..

Point-in-time ledger

Not available for VRCA yet: The point-in-time ledger arrives with this issuer's next re-crawl (sec_screen_v6)..

Notes by disclosure type

Not available for VRCA yet: no footnote text blocks on file for this filer in the ingested DERA files.

Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.

Educational content only. Not financial advice. TrendNalysis provides educational and informational financial analysis built from public SEC filings and economic data (FRED, BLS). It is not financial, investment, tax, or legal advice and is not a recommendation to buy or sell any security. Market pricing is not currently included. Past performance does not guarantee future results. Always do your own research and consult a licensed financial professional before investing.